MedPath

Spectral and temporal processing by prelingually deafened CI users.

Completed
Conditions
deafness, cochlear implant, prelingually deafeneddoofheid, cochleair implantaat, prelinguaal doof
Registration Number
NL-OMON19912
Lead Sponsor
dr. ir. J. Brokx, MUMC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

1. Mother tongue Dutch;

2. Normal reading skills;

Exclusion Criteria

There are no additional exclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For the listening task of part 1A the main study parameter is the electrode discrimination ability per electrode. The main study parameter of part 1B is the difference between subjects’ speech understanding with the standard and adapted speech programme. The<br>main study parameters of the listening task of part 2 are the mean<br>amplitude modulation detection thresholds of the prelingually and<br>postlingually deafened CI-users.
Secondary Outcome Measures
NameTimeMethod
If a SADE (Serious Adverse Device Effect) would occur, causing tissue damage or serious discomfort/distress to the subject, this implies the end of the study for this subject. This is mainly applicable for part 1A, since in part 1B and part 2 no additional medical device (different from the patients’ own clinical device) is used. However, if any other SAE occurs, not related to the use of the medical device, this also indicates the end of the study for this subject.
© Copyright 2025. All Rights Reserved by MedPath